Rakesh Bhan
Interventional Cardiology · Utica, NYNPI 1508863069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,041 and has fallen 76.8% since, to $242 in 2025. That places this record below the midpoint for interventional cardiology clinicians in NY, where the typical reported total is $8,047.
Across 108 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$438
- Boehringer Ingelheim$300
- Johnson & Johnson$188
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$165
- Cardiovascular Systems Inc.$142
- Boston Scientific$111
- plus $632 from 13 others
What the payments were for
- Consulting fees$251%
- Food & beverage$1,95299%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 9 | $438 |
| Boehringer Ingelheim | 21 | $300 |
| Johnson & Johnson | 16 | $188 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $165 |
| Cardiovascular Systems Inc. | 4 | $142 |
| Boston Scientific | 4 | $111 |
| AstraZeneca | 9 | $110 |
| Novartis | 6 | $88 |
| Medtronic | 3 | $75 |
| Amgen | 5 | $75 |
| Chiesi USA, Inc. | 5 | $64 |
| Amarin Pharma, Inc. | 3 | $50 |
| Abbott | 2 | $40 |
| Pfizer | 2 | $35 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Biotronik Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Merck | 1 | $14 |
How this compares
$1,977 in reported general payments places this provider in the 15th percentile of 382 interventional cardiology providers in New York.
Other interventional cardiology in Utica
- Sahil ParikhNew York$1.6M
- Deepak BhattNew York$1.6M
- Martin LeonNew York$1.5M
- Evan ShlofmitzRoslyn$951K
- Mohamed Azeem LatibBronx$816K
- Yili HuangElmhurst$699K
- Ali HaiderAstoria$492K
- Sripal BangaloreNew York$482K
- Ajay KirtaneNew York$462K
- David CohenRoslyn$392K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.